186 related articles for article (PubMed ID: 19033446)
1. A mechanism of sialylation functionally silences the hyaluronan receptor LYVE-1 in lymphatic endothelium.
Nightingale TD; Frayne ME; Clasper S; Banerji S; Jackson DG
J Biol Chem; 2009 Feb; 284(6):3935-45. PubMed ID: 19033446
[TBL] [Abstract][Full Text] [Related]
2. Binding of Hyaluronan to the Native Lymphatic Vessel Endothelial Receptor LYVE-1 Is Critically Dependent on Receptor Clustering and Hyaluronan Organization.
Lawrance W; Banerji S; Day AJ; Bhattacharjee S; Jackson DG
J Biol Chem; 2016 Apr; 291(15):8014-30. PubMed ID: 26823460
[TBL] [Abstract][Full Text] [Related]
3. Distinctive properties of the hyaluronan-binding domain in the lymphatic endothelial receptor Lyve-1 and their implications for receptor function.
Banerji S; Hide BR; James JR; Noble ME; Jackson DG
J Biol Chem; 2010 Apr; 285(14):10724-35. PubMed ID: 19887450
[TBL] [Abstract][Full Text] [Related]
4. The cortical actin network regulates avidity-dependent binding of hyaluronan by the lymphatic vessel endothelial receptor LYVE-1.
Stanly TA; Fritzsche M; Banerji S; Shrestha D; Schneider F; Eggeling C; Jackson DG
J Biol Chem; 2020 Apr; 295(15):5036-5050. PubMed ID: 32034091
[TBL] [Abstract][Full Text] [Related]
5. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium.
Prevo R; Banerji S; Ferguson DJ; Clasper S; Jackson DG
J Biol Chem; 2001 Jun; 276(22):19420-30. PubMed ID: 11278811
[TBL] [Abstract][Full Text] [Related]
6. Homodimerization of the Lymph Vessel Endothelial Receptor LYVE-1 through a Redox-labile Disulfide Is Critical for Hyaluronan Binding in Lymphatic Endothelium.
Banerji S; Lawrance W; Metcalfe C; Briggs DC; Yamauchi A; Dushek O; van der Merwe PA; Day AJ; Jackson DG
J Biol Chem; 2016 Nov; 291(48):25004-25018. PubMed ID: 27733683
[TBL] [Abstract][Full Text] [Related]
7. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan.
Banerji S; Ni J; Wang SX; Clasper S; Su J; Tammi R; Jones M; Jackson DG
J Cell Biol; 1999 Feb; 144(4):789-801. PubMed ID: 10037799
[TBL] [Abstract][Full Text] [Related]
8. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1.
Johnson LA; Prevo R; Clasper S; Jackson DG
J Biol Chem; 2007 Nov; 282(46):33671-33680. PubMed ID: 17884820
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1.
Johnson LA; Banerji S; Lawrance W; Gileadi U; Prota G; Holder KA; Roshorm YM; Hanke T; Cerundolo V; Gale NW; Jackson DG
Nat Immunol; 2017 Jul; 18(7):762-770. PubMed ID: 28504698
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan in the lymphatics: The key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking.
Jackson DG
Matrix Biol; 2019 May; 78-79():219-235. PubMed ID: 29425695
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell entry to lymphatic capillaries is orchestrated by CD44 and the hyaluronan glycocalyx.
Johnson LA; Banerji S; Lagerholm BC; Jackson DG
Life Sci Alliance; 2021 May; 4(5):. PubMed ID: 33687996
[TBL] [Abstract][Full Text] [Related]
12. FK506 induces lung lymphatic endothelial cell senescence and downregulates LYVE-1 expression, with associated decreased hyaluronan uptake.
Shrestha S; Cho W; Stump B; Imani J; Lamattina AM; Louis PH; Pazzanese J; Rosas IO; Visner G; Perrella MA; El-Chemaly S
Mol Med; 2020 Jul; 26(1):75. PubMed ID: 32736525
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the interaction of fibroblast growth factor-2 with the lymphatic endothelial cell marker LYVE-1.
Platonova N; Miquel G; Regenfuss B; Taouji S; Cursiefen C; Chevet E; Bikfalvi A
Blood; 2013 Feb; 121(7):1229-37. PubMed ID: 23264596
[TBL] [Abstract][Full Text] [Related]
14. Immunological functions of hyaluronan and its receptors in the lymphatics.
Jackson DG
Immunol Rev; 2009 Jul; 230(1):216-31. PubMed ID: 19594639
[TBL] [Abstract][Full Text] [Related]
15. Ectodomain Shedding of Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE-1) Is Induced by Vascular Endothelial Growth Factor A (VEGF-A).
Nishida-Fukuda H; Araki R; Shudou M; Okazaki H; Tomono Y; Nakayama H; Fukuda S; Sakaue T; Shirakata Y; Sayama K; Hashimoto K; Detmar M; Higashiyama S; Hirakawa S
J Biol Chem; 2016 May; 291(20):10490-500. PubMed ID: 26966180
[TBL] [Abstract][Full Text] [Related]
16. Lack of lymphatic vessel phenotype in LYVE-1/CD44 double knockout mice.
Luong MX; Tam J; Lin Q; Hagendoorn J; Moore KJ; Padera TP; Seed B; Fukumura D; Kucherlapati R; Jain RK
J Cell Physiol; 2009 May; 219(2):430-7. PubMed ID: 19170073
[TBL] [Abstract][Full Text] [Related]
17. The interaction between LYVE-1 with hyaluronan on the cell surface may play a role in the diversity of adhesion to cancer cells.
Du Y; Liu H; He Y; Liu Y; Yang C; Zhou M; Wang W; Cui L; Hu J; Gao F
PLoS One; 2013; 8(5):e63463. PubMed ID: 23717428
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan and Its Receptors: Key Mediators of Immune Cell Entry and Trafficking in the Lymphatic System.
Johnson LA; Jackson DG
Cells; 2021 Aug; 10(8):. PubMed ID: 34440831
[TBL] [Abstract][Full Text] [Related]
19. What is special about 200 kDa hyaluronan that activates hyaluronan receptor signaling?
Weigel PH; Baggenstoss BA
Glycobiology; 2017 Sep; 27(9):868-877. PubMed ID: 28486620
[TBL] [Abstract][Full Text] [Related]
20. TGFβ counteracts LYVE-1-mediated induction of lymphangiogenesis by small hyaluronan oligosaccharides.
Bauer J; Rothley M; Schmaus A; Quagliata L; Ehret M; Biskup M; Orian-Rousseau V; Jackson DG; Pettis RJ; Harvey A; Bräse S; Thiele W; Sleeman JP
J Mol Med (Berl); 2018 Feb; 96(2):199-209. PubMed ID: 29282520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
